Predicting hepatocellular carcinoma through cross-talk genes identified by risk pathways

Oncotarget
Lei LiuXiujie Chen

Abstract

Hepatocellular carcinoma (HCC) is the most frequent type of liver cancer with poor survival rate and high mortality. Despite efforts on the mechanism of HCC, new molecular markers are needed for exact diagnosis, evaluation and treatment. Here, we combined transcriptome of HCC with networks and pathways to identify reliable molecular markers. Through integrating 249 differentially expressed genes with syncretic protein interaction networks, we constructed a HCC-specific network, from which we further extracted 480 pivotal genes. Based on the cross-talk between the enriched pathways of the pivotal genes, we finally identified a HCC signature of 45 genes, which could accurately distinguish HCC patients with normal individuals and reveal the prognosis of HCC patients. Among these 45 genes, 15 showed dysregulated expression patterns and a part have been reported to be associated with HCC and/or other cancers. These findings suggested that our identified 45 gene signature could be potential and valuable molecular markers for diagnosis and evaluation of HCC.

References

Apr 4, 1997·Science·G K Michalopoulos, M C DeFrances
May 18, 2001·Nature·G I Evan, K H Vousden
May 2, 2006·Statistical Applications in Genetics and Molecular Biology·Gordon K Smyth
Oct 2, 2007·Statistics in Medicine·I R KönigUNKNOWN German Stroke Study Collaboration
Sep 9, 2008·Cell·Peggy P Hsu, David M Sabatini
Nov 8, 2008·Nucleic Acids Research·T S Keshava PrasadAkhilesh Pandey
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Jul 20, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anja LachenmayerJosep M Llovet
Nov 13, 2012·Nucleic Acids Research·Atanas KamburovRalf Herwig
Feb 15, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mamatha BhatGregory J Gores
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Jan 8, 2014·Nature Reviews. Clinical Oncology·Augusto Villanueva, Josep M Llovet
Mar 22, 2014·Molecular and Clinical Oncology·Yan-Jie ZhaoGuan-Cheng Li
Mar 17, 2015·Cell Reports·Ivo A HendriksAlfred C O Vertegaal
Apr 23, 2015·Nature·James E Bradner
Aug 23, 2016·Nature Genetics·Victoria E ClarkMurat Günel

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE64041
GSE95698

Methods Mentioned

BETA
biopsy
RNA-seq

Software Mentioned

Weka
Limma
R package “ randomForest
R package Limma
DAVID

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.